156 related articles for article (PubMed ID: 29750037)
1. Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy.
Hu CC; Weng CH; Chang LC; Lin CL; Chen YT; Hu CF; Hua MC; Chen LW; Chien RN
Ther Clin Risk Manag; 2018; 14():783-791. PubMed ID: 29750037
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study.
Ji D; Chen GF; Niu XX; Zhang M; Wang C; Shao Q; Wu V; Wang Y; Cheng G; Hurwitz SJ; Schinazi RF; Lau G
Metabol Open; 2021 Jun; 10():100090. PubMed ID: 33889834
[TBL] [Abstract][Full Text] [Related]
3. New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy.
Hu CC; Weng CH; Hua MC; Chang PH; Lin CL; Chen YT; Chien CH; Lin ST; Chien RN
J Interferon Cytokine Res; 2020 Feb; 40(2):82-91. PubMed ID: 31800346
[
